The pharmaceutical industry operates in one of the most highly regulated environments in the world. Yet, even with stringent internal controls, third-party risks remain a major vulnerability. Distributors, suppliers, agents, and contractors—often located in countries with varying legal frameworks—can expose pharmaceutical companies to bribery, corruption, and compliance failures. To tackle this growing concern, many pharma […]

In today’s competitive global marketplace, organizations face rising pressure to demonstrate integrity, ethical practices, and strong governance structures. Corruption, bribery, and unethical conduct not only damage reputations but also expose companies to legal penalties, financial loss, and diminished stakeholder confidence. One recognized tool to combat these risks is ISO 37001, the Anti-Bribery Management System standard. […]

Compliance with ISO 37001, the international standard for Anti-Bribery Management Systems (ABMS), is becoming increasingly important for organisations that aim to build credibility, maintain ethical standards, and reduce bribery risks. One of the key mechanisms in achieving and sustaining compliance is the internal audit process. Internal audits serve as a systematic and independent evaluation that […]